Salt CompositionYou Searched
Mirbeg S 25/5mg Tablet ER 10s
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Overactive bladder (OAB) symptoms
Customers also bought
More About Mirbeg-S
Benefits
In Overactive bladder (OAB) symptoms Mirbeg-S 25 Tablet ER helps to treat uncontrollable contractions (spasms) of the bladder muscles that cause frequent urination, urgent need to urinate, and inability to control passing of urine. It also relieves painful, or frequent urination and reduces urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Mirbeg-S 25 Tablet ER can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Mirbeg-S 25 Tablet ER is a combination of two medicines: Mirabegron and Solifenacin. Mirabegron is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax. Solifenacin is an antimuscarinic. It also works by relaxing muscles of the urinary bladder. In this way, it works to prevent frequent, urgent, or uncontrolled urge of urination.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Mirbeg-S 25 Tablet ER .
Seek medical advice from your doctor: Information regarding the use of Mirbeg-S 25 Tablet ER during pregnancy is not available. Doctor consultation is advised.
Seek medical advice from your doctor: Information regarding the use of Mirbeg-S 25 Tablet ER during breastfeeding is not available. Doctor consultation is advised.
Seek medical advice from your doctor: It is not known whether Mirbeg-S 25 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Seek medical advice from your doctor: There is limited information available on the use of Mirbeg-S 25 Tablet ER in patients with kidney disease. Doctor consultation is advised.
Seek medical advice from your doctor: There is limited information available on the use of Mirbeg-S 25 Tablet ER in patients with liver disease. Doctor consultation is advised.
Manufacturer Address
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra
References
Brown JH, Brandl K, Wess J. Muscarinic Receptor Agonists and Antagonists. In: Brunton LL, Hilal-Dandan R, Knollmann BC (Editors). Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 13th ed. New York, NY: McGraw-Hill Education; 2018. pp. 149-161
Pappano AJ. Cholinoceptor-Blocking Drugs. In: Katzung BG, Masters SB, Trevor AJ (Editors). Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 113-126
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
